AUGUST 14, 2020
‘Marching-In’ on Remdesivir: Wrong, Pointless and Bad for Patients
MORNING CONSULT - Peter Kolchinsky, PhD
VIEW PDFJUNE 9, 2020
RA Capital Management COVID-19 Town Hall June 2020
Managing Partner Peter Kolchinsky joins TechAtlas Associates Alyssa Larson and Shan Shan Wang to host a virtual tour of our COVID-19 Therapeutic Landscape Map. The presentation highlights the various classes of vaccines in development (which ones we expect will get to market first, which are most scalable, which seem best suited to become seasonal products) and drugs in development (which ones we think are most likely to work, which might be combinable, and what that means for addressing our fears). Peter also addresses investor-submitted questions.
APRIL 21, 2020
Innovation and Biotech in the Time of COVID-19: What's Happening on the Front Lines
LABCENTRAL - Joshua Resnick, MD
RA Capital's Joshua Resnick, MD, joins biotech industry leaders, experts, and entrepreneurs to discuss COVID-19 and its impact on innovation.
APRIL 9, 2020
The ventilator shortage is here. The medication shortage is next.
THE WASHINGTON POST - Joshua Resnick, MD
Read ArticleAPRIL 8, 2020
Prospects for a Coronavirus Vaccine
CITY JOURNAL - Peter Kolchinsky, PhD
MARCH 17, 2020
RA Capital Management COVID-19 Town Hall March 2020
Peter Kolchinsky, Founder and Managing Partner, and Josh Resnick, Managing Director and Co-Head of Venture, share their thoughts on the COVID-19 virus, including how one can mitigate the risks of getting the disease, what one can expect should they contract it, the treatments currently available and those that are on the horizon, and the impact this coronavirus could have on both the healthcare system and the global biotech sector.
MARCH 5, 2020
Coronavirus spending: an expense — or an investment?
STAT - Jessica Sagers, PhD
Read Article